MARC details
000 -LEADER |
fixed length control field |
03621cam a22005057a 4500 |
001 - CONTROL NUMBER |
control field |
BDZ0006612892 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
StDuBDS |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20210119105851.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
070323s2007 nyua b 001 0 eng d |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2007272501 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780849339721 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780849339721 (Cloth) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(DLC)2007272501 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(DLC)2007272501 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
UNM |
Transcribing agency |
UNM |
Modifying agency |
BAKER |
-- |
YDXCP |
-- |
UAT |
-- |
IXA |
-- |
DLC |
-- |
StDuBDSZ |
050 #0 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS189 |
Item number |
.W57 2007 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
TDCW |
Source |
thema |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
KND |
Source |
thema |
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 NAL |
245 00 - TITLE STATEMENT |
Title |
Good manufacturing practices for pharmaceuticals / |
Statement of responsibility, etc. |
edited by Joseph D. Nally. |
250 ## - EDITION STATEMENT |
Edition statement |
6th ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
New York, NY : |
Name of publisher, distributor, etc. |
Informa Healthcare, |
Date of publication, distribution, etc. |
c2007. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
viii, 398 p. : |
Other physical details |
ill. ; |
Dimensions |
26 cm. |
440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
Drugs and the pharmaceutical sciences, |
International Standard Serial Number |
0360-2583 ; |
Volume/sequential designation |
v. 169 |
490 #0 - SERIES STATEMENT |
Series statement |
Drugs and the pharmaceutical sciences, |
Volume/sequential designation |
v. 169 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
1.Status and applicability of U.S. regulations: current good manufacturing practices in manufacturing, processing, packaging, and holding of drugs. Joseph D. Nally -- 2.Finished pharmaceuticals: general provisions subpart A. Joseph D. Nally -- 3.Organization and personnel: subpart B. Joanne W. Cochran and Joseph D. Nally -- 4.Buildings and facilities: subpart C. Robert Del Ciello -- 5.Equipment: subpart D -- 6.Control of compoents and drug product containers and closures: subpart E. Arlyn R. Sibille -- 7.Production and process controls: subpart F. Joseph D. Nally and Michael D. Karaim -- 8.Packaging and labeling control: subpart G. Arlyn R. Sibille -- 9.Holding and distribution: subpart H. Joseph D. Nally -- 10.Laboratory controls: subpart I. Wayne J. DeWitte and Alex M. Hoinowski -- 11.Records and reports: subpart J. Arlyn R. Sibille, Steven Ostrove, Joseph D. Nally, and Laura N. Nally -- 12.Returned and salvaged drug products: subpart K.Joseph D. Nally -- 13.Repacking and relabeling. Joseph D. Nally -- 14.Quality systems and risk management approaches. Joseph D. Nally and Laura L. Nally -- 15.Clinical trial supplies and current good manufacturing. Graham Bunn -- 16.Contracting and outsourcing. Graham Bunn -- 17.Active pharmaceutical ingredients. P. Denis Celentano -- 18.Bulk pharmaceutical ingredients. Irwin Silverstein -- 19.Recalls, warning lettters, seizures and injunctions: CGMP enforcement alternatives in the United States. Joseph D. Nally -- 20.Controlled substances safeguards. Joseph D. Nally -- 21.The inspectioin procedure for compliance in the United States: the regulatee is inspected: the rationale for inspection (21 USC 373, 374). Joseph D. Nally -- 23.Worldwide good manufacturing proactices. Joseph D. Nally -- 24.Quality approaches: ISO 9000, Malcolm Baldrige, and Six Sigma. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical industry |
General subdivision |
Quality control |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Standards |
Geographic subdivision |
United States |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical Preparations |
General subdivision |
standard |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Industry |
General subdivision |
standard |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Legislation, Drug. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Quality Control. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Technology, Pharmaceutical |
General subdivision |
standard |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical chemistry & technology |
Source of heading or term |
thema |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Manufacturing industries |
Source of heading or term |
thema |
651 #2 - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Geographic name |
United States. |
9 (RLIN) |
1504 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Nally, Joseph D. |
902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
a |
170814 |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
a |
.b10455401 |
b |
main |
c |
- |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Suppress in OPAC |
0 |
Source of classification or shelving scheme |
Dewey Decimal Classification |
960 ## - PHYSICAL LOCATION (RLIN) |
Physical location, PLOC (RLIN) |
main |
Copies |
1 |
Cataloging date |
110622 |
Code1 |
- |
Code2 |
- |
Code3 |
- |
Code4 |
- |
Acquisition type - method of paying for the material |
p |
Claim – claiming activity |
- |
Estimated price |
155.00 |
Form – physical form |
b |
Fund |
none |
Order date |
2011-05-05 |
Order note |
- |
Order type |
f |
Receiving action |
- |
Received date |
2011-06-21 |
Receiving location |
a |
Billing location |
q |
Status |
a |
Temporary shelving location |
p |
Vendor |
star |
Language |
eng |
Country |
enk |
Volumes |
0 |
Millennium order record number |
.o10105232 |
961 ## - REQUESTOR & SELECTOR |
Note |
Title Reprinting order recorded |
Selector |
Colin Conway |
Locations |
main |
Funds |
none |
998 ## - LOCAL CONTROL INFORMATION (RLIN) |
Operator's initials, OID (RLIN) |
0 |
Cataloger's initials, CIN (RLIN) |
110505 |
First Date, FD (RLIN) |
m |
Local |
a |
-- |
- |
-- |
0 |